Cardiovascular Risk Reduction Approval: Several GLP-1s have gained FDA approval for cardiovascular benefits, broadening their clinical utility
Glutathione, a powerful antioxidant agent, help neutralize the free radicals while retaining the skin barrier
For example, in the EMPA-REG OUTCOME trial, patients randomized to receive empagliflozin experienced a significant reduction in cardiovascular death, all-cause mortality, and hospitalization for heart failure compared to placebo despite only modest differences in HbA1c between groups [22]
Ensure your thyroid is optimised first, monitor your symptoms closely, and use structured blood testing to keep an eye on your hormone levels as your body weight changes
Rosenson, R
The National Institutes of Health maintains a database of cases of liver failure due to medications and supplements at livertox.nih.gov